Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
Date
2007Author
Can, Günay
KARABULUT, A.
ALBAYRAK, S.
ONAT, A.
HERGENC, G.
YAZICI, M.
Metadata
Show full item recordAbstract
Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.
Collections
- Makale [92796]